Processa Pharmaceuticals, Inc. — Director's Dealing 2023

Nov 28, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Processa Pharmaceuticals, Inc. (PCSA)
CIK: 0001533743
Period of Report: 2023-11-21

Reporting Person: Yorke Justin W (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-21	Common Stock	J	55267	—	Disposed	464623	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	74729	Direct

Footnotes

F1: Represents a transfer of shares to a fund that the Reporting Person does not manage. As a result, the reporting person is no longer deemed to be the beneficial owner of such shares.